National Jewish Health

National Jewish Health (previously National Jewish Medical and Research Center) is a research institute located in Denver, Colorado specializing in respiratory, immune and allergic research and treatment. It was founded in 1899 to treat tuberculosis, and is today considered one of the world's best medical research and treatment centers. It is a non-sectarian institution but received funding from B'nai B'rith until the 1950s. Today, clinical functions at National Jewish are limited to research, diagnosis, and ambulatory outpatient care. By the late 19th century, Colorado and the American Southwest had become famous for the health benefits of a dry, sunny climate. At that time, the only known treatment for tuberculosis (TB) was clean air and sunshine and hundreds of people with tuberculosis descended upon Denver in hopes of finding a miracle cure for what was then the nation’s leading cause of death. Consequently, many TB sufferers spent their last dollars coming to Colorado. By the 1890s, it was estimated that one out of every three residents of the state was there for respiratory reasons. However, no facilities existed to provide treatment or shelter to these victims.

Website
http://www.njc.org/index.aspx
Wikipedia
http://en.wikipedia.org/wiki/National_Jewish_Health

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Immunology

Replacement with non-allergenic joints can provide relief

Allergies to metals used in artificial joint hardware, or to the bone cement used to secure them, can cause severe pain, itching, swelling and loosening of the joint, according to research at National Jewish Health. Replacement ...

Medical research

Allergic asthma transforms cells of the airway

New research at National Jewish Health shows that allergic asthma fundamentally transforms the human airway, reducing cells' ability to remove pollutants and fight infections. Allergic asthma, the most common form of the ...

Medications

Triple-combination therapy helps more people with cystic fibrosis

Researchers at National Jewish Health and around the world report today that a three-drug combination of medications can improve lung function, reduce exacerbations and improve quality of life for people with cystic fibrosis ...

Medical research

Compound in breast milk fights harmful bacteria

Researchers at National Jewish Health and the University of Iowa have identified a compound in human breast milk that fights infections by harmful bacteria while allowing beneficial bacteria to thrive. Human breast milk has ...

Diseases, Conditions, Syndromes

Nintedanib slows progression for broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases. The findings, published in the New England ...

page 1 from 7